Nea Management Company, LLC Affimed N.V. Transaction History

Nea Management Company, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 02, 2021	SELL	$7.78 - $11.4 $7.61 Million - $11.2 Million	-978,774 Reduced 18.11%	4,426,488 $37.6 Million
Q1 2021 May 14, 2021	SELL	$5.12 - $8.48 $3.69 Million - $6.12 Million	-721,226 Reduced 11.77%	5,405,262 $42.8 Million
Q4 2019 Jan 24, 2020	BUY	$2.25 - $3.07 $2.22 Million - $3.03 Million	987,600 Added 19.22%	6,126,488 $16.8 Million
Q1 2018 May 10, 2018	BUY	$1.25 - $2.65 $1.56 Million - $3.31 Million	1,250,000 Added 32.14%	5,138,888 $9.51 Million
Q3 2017 Nov 03, 2017	BUY	$1.95 - $2.25 $7.58 Million - $8.75 Million	3,888,888	3,888,888 $8.75 Million

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $520M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of Nea Management Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Nea Management Company, LLC with notifications on news.